Nearly 1,400 people by Friday afternoon had signed a change.org petition that was started by a high school student in ...

Trump administration seeking access to database of immigrant minors How to delete your personal data from the internet: ...

Trump administration seeking access to database of immigrant minors How to delete your personal data from the internet: ...

A $10.3 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, will fund ...

Lee — With a proposal by Vertex Towers LLC for a special permit to construct a 150-foot cell tower on Beaver Dam Road, the ...

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.

Whether you're shopping for a holistic health connoisseur or a fitness enthusiast or, our editors' favorite picks have you ...

The best tech tutorials and in-depth reviews Issues delivered straight to your door or device ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.